Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAES: Epoetin Beta vs Darbepoetin in Hemodialysis Patients
NCT00551603Phase 4Withdrawn
- Sponsor
- Anemia Working Group Romania
- Start
- Jul 2006
- Primary completion
- Dec 2008
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of epoetin beta in anemia (2 arms), sponsored by Anemia Working Group Romania. Primary endpoints: Hemoglobin Level at 80 weeks and Monthly ESA Dose per Dry Body Weight at 80 weeks. Planned start Jul 2006; status: withdrawn.
02
Drugs
epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00551603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00551603.